[Medical treatment of BPH].
Four therapeutic classes can be used for the treatment of BPH: alphablockers, 5 alpha reductase inhibitors (5ARI), muscrinic receptor antagonists, and plant extracts. Two combination therapies have been proven to be efficient: 5ARI - alphablockers, and muscarinic receptor antagonists - alphablockers. Alphablockers have the advantage to be efficient quickly. 5ARI decrease prostate volume. Efficacy of plant extracts is still discussed, but their tolerance is excellent. Muscrinic receptor antagonists can be a viable treatment option for men with predominantly bladder storage symptoms but without bladder outlet obstruction.
Descazeaud
A
A
Service de chirurgie urologique, hôpital Dupuytren, CHU de Limoges, Limoges, France. aureliendescazeaud@gmail.com
D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*